SMO-话题@MedSci

#SMO#

285篇内容 | 3652人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2024738, encodeId=b9572024e38cd, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014：循证医学引导下的子宫颈癌个体化治疗, objectType=article, longId=38106, objectId=f0f0381067a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0f0381067a, replyNumber=0, likeNumber=73, createdTime=2015-05-02, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0f0381067a, moduleTitle=CSMO 2014：循证医学引导下的子宫颈癌个体化治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0f0381067a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024741, encodeId=91902024e4108, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=ESMO 2014 ：肛管鳞癌临床实践指南解读, objectType=article, longId=39890, objectId=f25c398905e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f25c398905e, replyNumber=0, likeNumber=50, createdTime=2015-02-17, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f25c398905e, moduleTitle=ESMO 2014 ：肛管鳞癌临床实践指南解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f25c398905e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024718, encodeId=a18a2024e183b, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014：王景文教授谈造血干细胞移植在治疗鼻型结外NK/T细胞淋巴瘤中的地位, objectType=article, longId=37659, objectId=09a53e6592b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09a53e6592b, replyNumber=0, likeNumber=61, createdTime=2014-12-20, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09a53e6592b, moduleTitle=CSMO 2014：王景文教授谈造血干细胞移植在治疗鼻型结外NK/T细胞淋巴瘤中的地位, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=09a53e6592b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024734, encodeId=19062024e3457, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014：杨红鹰教授谈乳腺癌分子检测评判标准的更新及临床意义, objectType=article, longId=38043, objectId=02723804379, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02723804379, replyNumber=0, likeNumber=61, createdTime=2015-05-31, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02723804379, moduleTitle=CSMO 2014：杨红鹰教授谈乳腺癌分子检测评判标准的更新及临床意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02723804379)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024717, encodeId=20b52024e1741, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014：牛晓辉教授解读2014年骨肿瘤NCCN指南, objectType=article, longId=37658, objectId=a5523e6587c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5523e6587c, replyNumber=0, likeNumber=54, createdTime=2015-04-21, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5523e6587c, moduleTitle=CSMO 2014：牛晓辉教授解读2014年骨肿瘤NCCN指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5523e6587c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024725, encodeId=06932024e25eb, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014 ：戒烟治疗, objectType=article, longId=37820, objectId=c17b3e82087, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c17b3e82087, replyNumber=0, likeNumber=67, createdTime=2015-06-15, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c17b3e82087, moduleTitle=CSMO 2014 ：戒烟治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c17b3e82087)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024737, encodeId=20ac2024e37e2, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014：徐建明教授谈胃癌的耐药机制和分子分型的探讨, objectType=article, longId=38046, objectId=782038046e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=782038046e8, replyNumber=0, likeNumber=77, createdTime=2014-10-05, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=782038046e8, moduleTitle=CSMO 2014：徐建明教授谈胃癌的耐药机制和分子分型的探讨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=782038046e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024695, encodeId=04642024695e2, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014：李凯教授谈靶向药物的效果评估, objectType=article, longId=37524, objectId=d6d93e524ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6d93e524ea, replyNumber=0, likeNumber=59, createdTime=2014-07-19, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6d93e524ea, moduleTitle=CSMO 2014：李凯教授谈靶向药物的效果评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6d93e524ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024693, encodeId=373a202469354, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014：陈强教授谈胃癌腹腔种植转移的防治, objectType=article, longId=37521, objectId=406e3e5219e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=406e3e5219e, replyNumber=0, likeNumber=70, createdTime=2014-07-31, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=406e3e5219e, moduleTitle=CSMO 2014：陈强教授谈胃癌腹腔种植转移的防治, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=406e3e5219e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024716, encodeId=ab972024e16ae, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014 ：整合素αvβ6在消化肿瘤领域的研究进展, objectType=article, longId=37612, objectId=3fd53e61225, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fd53e61225, replyNumber=0, likeNumber=75, createdTime=2014-09-23, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fd53e61225, moduleTitle=CSMO 2014 ：整合素αvβ6在消化肿瘤领域的研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fd53e61225)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024683, encodeId=f59c202468338, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014 ：田口铁男教授谈实体瘤的诱导化疗, objectType=article, longId=37510, objectId=24173e510e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24173e510e8, replyNumber=0, likeNumber=64, createdTime=2015-04-29, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24173e510e8, moduleTitle=CSMO 2014 ：田口铁男教授谈实体瘤的诱导化疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24173e510e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024720, encodeId=12a82024e2027, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014：马骏教授谈基于现代影像技术的鼻咽癌综合治疗, objectType=article, longId=37661, objectId=b6043e66196, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6043e66196, replyNumber=0, likeNumber=76, createdTime=2015-04-24, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6043e66196, moduleTitle=CSMO 2014：马骏教授谈基于现代影像技术的鼻咽癌综合治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6043e66196)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024681, encodeId=a0cd202468183, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=任科：全球SMO大盘点, objectType=article, longId=36624, objectId=030e366241b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=030e366241b, replyNumber=0, likeNumber=76, createdTime=2015-05-06, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=030e366241b, moduleTitle=任科：全球SMO大盘点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=030e366241b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024739, encodeId=b8722024e3903, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014：EGFR抑制剂的新进展与新思路, objectType=article, longId=38107, objectId=26de3810e26, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26de3810e26, replyNumber=0, likeNumber=99, createdTime=2014-12-16, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26de3810e26, moduleTitle=CSMO 2014：EGFR抑制剂的新进展与新思路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26de3810e26)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024751, encodeId=c9892024e512e, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=ESMO 2014：肺鳞癌、头颈鳞癌：阿法替尼好戏连台, objectType=article, longId=41299, objectId=25e141299c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25e141299c6, replyNumber=0, likeNumber=68, createdTime=2015-03-21, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25e141299c6, moduleTitle=ESMO 2014：肺鳞癌、头颈鳞癌：阿法替尼好戏连台, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25e141299c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024740, encodeId=99ba2024e404e, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014：胰腺癌内科治疗策略及优化, objectType=article, longId=38108, objectId=cf343810855, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf343810855, replyNumber=0, likeNumber=72, createdTime=2015-03-24, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf343810855, moduleTitle=CSMO 2014：胰腺癌内科治疗策略及优化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf343810855)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024733, encodeId=40372024e3397, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014：张国君教授谈乳腺癌内分泌耐药机制, objectType=article, longId=38042, objectId=97003804220, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97003804220, replyNumber=0, likeNumber=80, createdTime=2014-10-05, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97003804220, moduleTitle=CSMO 2014：张国君教授谈乳腺癌内分泌耐药机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97003804220)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024709, encodeId=43bc2024e09e8, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014：胰腺癌的放疗和化疗的综合治疗, objectType=article, longId=37605, objectId=7ca63e605c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ca63e605c2, replyNumber=0, likeNumber=74, createdTime=2015-06-09, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ca63e605c2, moduleTitle=CSMO 2014：胰腺癌的放疗和化疗的综合治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ca63e605c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024750, encodeId=a5212024e5020, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=ESMO 2014：研究结果公布, objectType=article, longId=41298, objectId=0f4441298b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f4441298b0, replyNumber=0, likeNumber=74, createdTime=2015-05-06, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f4441298b0, moduleTitle=ESMO 2014：研究结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f4441298b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024752, encodeId=a4fa2024e52ad, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=ESMO 2014：克唑替尼可有效抑制ROS1阳性非小细胞肺癌的进展, objectType=article, longId=41397, objectId=a5934139eb6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5934139eb6, replyNumber=0, likeNumber=82, createdTime=2015-01-23, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5934139eb6, moduleTitle=ESMO 2014：克唑替尼可有效抑制ROS1阳性非小细胞肺癌的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5934139eb6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SMO

2020-05-29

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014：循证医学引导下的子宫颈癌个体化治疗

2015-05-02

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

ESMO 2014 ：肛管鳞癌临床实践指南解读

2015-02-17

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014：王景文教授谈造血干细胞移植在治疗鼻型结外NK/T细胞淋巴瘤中的地位

2014-12-20

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014：杨红鹰教授谈乳腺癌分子检测评判标准的更新及临床意义

2015-05-31

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014：牛晓辉教授解读2014年骨肿瘤NCCN指南

2015-04-21

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014 ：戒烟治疗

2015-06-15

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014：徐建明教授谈胃癌的耐药机制和分子分型的探讨

2014-10-05

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014：李凯教授谈靶向药物的效果评估

2014-07-19

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014：陈强教授谈胃癌腹腔种植转移的防治

2014-07-31

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014 ：整合素αvβ6在消化肿瘤领域的研究进展

2014-09-23

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014 ：田口铁男教授谈实体瘤的诱导化疗

2015-04-29

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014：马骏教授谈基于现代影像技术的鼻咽癌综合治疗

2015-04-24

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

任科：全球SMO大盘点

2015-05-06

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014：EGFR抑制剂的新进展与新思路

2014-12-16

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

ESMO 2014：肺鳞癌、头颈鳞癌：阿法替尼好戏连台

2015-03-21

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014：胰腺癌内科治疗策略及优化

2015-03-24

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014：张国君教授谈乳腺癌内分泌耐药机制

2014-10-05

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014：胰腺癌的放疗和化疗的综合治疗

2015-06-09

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

ESMO 2014：研究结果公布

2015-05-06

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

ESMO 2014：克唑替尼可有效抑制ROS1阳性非小细胞肺癌的进展

2015-01-23

科室
- - 订阅+
  - 更多科室
工具
服务